Source: Medscape, by Wayne J. Guglielmo, MA

A complaint against a Texas doctor who was reported for malpractice to the state medical board for apparently prescribing hydroxychloroquine to treat several coronavirus patients has been dismissed, says a story in The Texan, a subscription-based news organization.

The doctor, Richard Urso, MD, a Houston ophthalmologist, has been an outspoken proponent of hydroxychloroquine and is a member of America’s Frontline Doctors.

In the complaint against him, Urso was accused of violating the state’s Medical Practice Act, which sets out the rules for practicing doctors and other healthcare professionals.

In an October 16 letter to Urso, though, the Texas Medical Board (TMB) said it was dismissing the complaint against him because it had “determined there was insufficient evidence to prove that a violation of the Medical Practice Act [had] occurred.” Although the board didn’t specifically mention hydroxychloroquine, it noted that Urso’s care of three patients was “appropriate” and that his use of social media to “discuss treatments for COVID-19” met the standard of care.

Why did the TMB feel compelled to investigate the complaint against Urso — or any doctor who uses alternative medicine to treat COVID-19? The answer is in an earlier press release.

On July 31, the TMB advised such doctors to tread carefully, urging them to refer to applicable “laws and Board rules.” It further noted: “If the Board were to receive a complaint, it would be reviewed following the Board’s standard enforcement process…. The Board may also investigate complaints for false, misleading or deceptive advertising, which could include for assuring a permanent cure for an incurable disease.”

The next month, TMB President Sherif Z. Zaafran, MD, an anesthesiologist, felt the need to further clarify the board’s position: “The Texas Medical Board has never prohibited the use of Hydroxychloroquine alone, or in conjunction with other drugs, for the treatment of COVID-19. In fact, the TMB does not prohibit any drug or treatment…. The off-label use of Hydroxychloroquine as an alternative therapy for COVID-19 patients is completely permissible” as long as “physicians…provide full disclosure of treatment options, side effects, and obtain informed consent.”





Related:

C19study.com update: Now 118 international studies (71 peer reviewed) show positive hydroxychloroquine treatment outcomes

Belgium Study: Low-dose Hydroxychloroquine Therapy and Mortality (Lowered) in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants

Italy Study 3,451 patients: Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

Italian Study: Hydroxychloroquine Cut Death Risk 66 Percent

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories